Plus   Neg

Nestle Says About 84% Aimmune Shares Tendered

Nestle SA (NSRGY.PK,NSTR.L) said, in an update on results of tender offer for Aimmune Therapeutics (AIMT), that about 43.44 million Aimmune shares were validly tendered. It represented about 84% of the outstanding shares of Aimmune.

The minimum tender condition to the consummation of the offer has been satisfied, Nestle

In late-August, Nestlé offered to buy Aimmune Therapeutics for $34.50 per share. The offer expired on October 9, 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Santa Cruz Bicycles LLC has recalled certain model year 2020 bicycles with aluminum frames citing fall risks, according to the U.S. Consumer Product Safety Commission. The recall involves about 2,900 units of model year 2020 Auminum Santa Cruz and Juliana Bicycles. In addition, about 216 were sold in Canada. AstraZeneca is mulling an additional global trial to confirm the 90% efficacy rate of its Covid-19 vaccine candidate at lower dosage, Bloomberg news quoted Chief Executive Officer Pascal Soriot as saying. In an interview, Soriot noted that instead of adding the trial to an ongoing U.S. process, the company might launch a fresh study to evaluate efficacy of lower dosage of its vaccine that perform U.S. airline Delta Air Lines, Inc. and its Italian codeshare partner Alitalia are planning to launch quarantine-free, COVID-free flights between U.S. and Europe through new testing protocols, starting in December. In a statement, Delta said it has signed deals with airports and governments eliminating quarantine requirements on COVID-tested flights connecting Atlanta and Rome.
Follow RTT